Descriptor English: | Xanthine | ||||
Descriptor Spanish: |
Xantina
| ||||
Descriptor Portuguese: | Xantina | ||||
Descriptor French: | Xanthine | ||||
Tree number(s): |
D03.132.960.938 D03.633.100.759.758.824.938 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D019820 | ||||
Scope note: | A purine base found in most body tissues and fluids, certain plants, and some urinary calculi. It is an intermediate in the degradation of adenosine monophosphate to uric acid, being formed by oxidation of hypoxanthine. The methylated xanthine compounds caffeine, theobromine, and theophylline and their derivatives are used in medicine for their bronchodilator effects. (Dorland, 28th ed) |
||||
Annotation: | a specific chem: do not confuse with XANTHINES or XANTHENES |
||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Entry Combination: |
analogs & derivatives:Xanthines
|
||||
Registry Number: | 1AVZ07U9S7 | ||||
Previous Indexing: |
Xanthines (1980-1997) |
||||
Public MeSH Note: | 98; XANTHINE was indexed under XANTHINES 1981-97 |
||||
History Note: | 98; use XANTHINE (NM) 1980-97 |
||||
DeCS ID: | 33417 | ||||
Unique ID: | D019820 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1998/01/01 | ||||
Date of Entry: | 1997/06/20 | ||||
Revision Date: | 2016/06/01 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Xanthine
- Preferred
Concept UI |
M0029424 |
Scope note | A purine base found in most body tissues and fluids, certain plants, and some urinary calculi. It is an intermediate in the degradation of adenosine monophosphate to uric acid, being formed by oxidation of hypoxanthine. The methylated xanthine compounds caffeine, theobromine, and theophylline and their derivatives are used in medicine for their bronchodilator effects. (Dorland, 28th ed) |
Preferred term | Xanthine |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey